Literature DB >> 24340311

What is the best regimen for Helicobacter pylori eradication in Canadian Arctic Aboriginals?

Nicola Jones.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24340311      PMCID： PMC3915009          DOI： 10.1155/2013/856395

Source DB:  PubMed          Journal:  Can J Gastroenterol        ISSN： 0835-7900            Impact factor:   3.522


× No keyword cloud information.
  4 in total

1.  Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report.

Authors:  Peter Malfertheiner; Francis Megraud; Colm A O'Morain; John Atherton; Anthony T R Axon; Franco Bazzoli; Gian Franco Gensini; Javier P Gisbert; David Y Graham; Theodore Rokkas; Emad M El-Omar; Ernst J Kuipers
Journal:  Gut       Date:  2012-05       Impact factor: 23.059

Review 2.  Helicobacter pylori in First Nations and recent immigrant populations in Canada.

Authors:  Nicola Jones; Naoki Chiba; Carlo Fallone; Alan Thompson; Richard Hunt; Kevan Jacobson; Karen Goodman
Journal:  Can J Gastroenterol       Date:  2012-02       Impact factor: 3.522

3.  A randomized controlled trial comparing sequential with triple therapy for Helicobacter pylori in an Aboriginal community in the Canadian North.

Authors:  Amy L Morse; Karen J Goodman; Rachel Munday; Hsiu-Ju Chang; John Wi Morse; Monika Keelan; Janis Geary; Veldhuyzen van Zanten Sander
Journal:  Can J Gastroenterol       Date:  2013-12       Impact factor: 3.522

4.  Rational Helicobacter pylori therapy: evidence-based medicine rather than medicine-based evidence.

Authors:  David Y Graham; Yi-Chia Lee; Ming-Shiang Wu
Journal:  Clin Gastroenterol Hepatol       Date:  2013-06-08       Impact factor: 11.382
  4 in total
  1 in total

1.  Twenty "must-read" research articles for primary care providers in Nunavik: scoping study and development of an information tool.

Authors:  Vincent Paquin; Glenda Sandy; Gentiane Perrault-Sullivan; Gabriel Fortin; Michel Cauchon; Christopher Fletcher; Jean Ouellet; Mélanie Lemire
Journal:  Int J Circumpolar Health       Date:  2019-12       Impact factor: 1.228
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.